Literature DB >> 25479930

A Defective Oxidative Burst and Impaired Antigen Presentation are Hallmarks of Human Visceral Leishmaniasis.

Susmita Roy1, Debanjan Mukhopadhyay1, Shibabrata Mukherjee1, Susmita Ghosh1, Shishir Kumar2, Kumkum Sarkar2, Dipankar Pal2, Pratik Bhowmik2, Kausik Mandal2, Dolanchampa Modak2, Subhasish Kamal Guha2, Netai Pramanik2, Rama Prosad Goswami2, Bibhuti Saha2, Mitali Chatterjee3.   

Abstract

PURPOSE: Survival of the Leishmania parasite within monocytes hinges on its ability to effectively nullify their microbicidal effector mechanisms. Accordingly, this study aimed to delineate this biological niche in patients with visceral leishmaniasis (VL).
METHODS: In monocytes, the redox status, antigen presenting capacity, expression of Toll-like receptors (TLRs), co-stimulatory molecules (CD80/86) and generation of intracellular cytokines (IL-8, IL-1β, IL-10 and LAP-TGF-β1) was measured by flow cytometry, levels of circulating cytokines (IL-1β, IL-6, TNF-α, IL-8, IL-4, IL-13, IL-10 and GM-CSF) by ELISA and arginase activity by spectrophotometry.
RESULTS: Within monocytes, generation of an oxidative burst was markedly attenuated as evident by decreased generation of nitric oxide and reactive oxygen species, concomitant with raised levels of thiols. This was accompanied by lowered frequency of TLR4(+) monocytes, but the arginase activity remained unaltered. Pathogen persistence was enhanced by the predominance of anti-inflammatory cytokines within monocytes, notably IL-10. Alongside, development of adaptive immunity was severely attenuated as manifested by a pronounced impairment of antigen presentation and co-stimulation evident by down regulation of CD54, HLA-DR and CD86. Treatment corrected the redox imbalance and reversed the impaired antigen presentation.
CONCLUSIONS: In VL, monocyte functions were severely impaired facilitating parasite persistence; anti-leishmanial chemotherapy mediated parasite elimination through modulation of the macrophage microenvironment by restoring its redox status and antigen presenting capacity.

Entities:  

Keywords:  Antigen presentation; Leishmania donovani; arginase; co-stimulation; nitric oxide; toll like receptors; visceral Leishmaniasis

Mesh:

Substances:

Year:  2014        PMID: 25479930     DOI: 10.1007/s10875-014-0115-3

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  49 in total

Review 1.  How do protozoan parasites survive inside macrophages?

Authors:  C Bogdan; M Röllinghoff
Journal:  Parasitol Today       Date:  1999-01

2.  Arginase and polyamine synthesis are key factors in the regulation of experimental leishmaniasis in vivo.

Authors:  Pascale Kropf; José M Fuentes; Eva Fähnrich; Luis Arpa; Shanthi Herath; Verena Weber; Germán Soler; Antonio Celada; Manuel Modolell; Ingrid Müller
Journal:  FASEB J       Date:  2005-04-05       Impact factor: 5.191

3.  Coinfection of Leptomonas seymouri and Leishmania donovani in Indian leishmaniasis.

Authors:  Susmita Ghosh; Priyanka Banerjee; Avijit Sarkar; Simanti Datta; Mitali Chatterjee
Journal:  J Clin Microbiol       Date:  2012-05-23       Impact factor: 5.948

Review 4.  Leishmaniasis: complexity at the host-pathogen interface.

Authors:  Paul Kaye; Phillip Scott
Journal:  Nat Rev Microbiol       Date:  2011-07-11       Impact factor: 60.633

5.  Splenic cytokine responses in Indian kala-azar before and after treatment.

Authors:  R T Kenney; D L Sacks; A A Gam; H W Murray; S Sundar
Journal:  J Infect Dis       Date:  1998-03       Impact factor: 5.226

Review 6.  Modulation of the arginase pathway in the context of microbial pathogenesis: a metabolic enzyme moonlighting as an immune modulator.

Authors:  Priyanka Das; Amit Lahiri; Ayan Lahiri; Dipshikha Chakravortty
Journal:  PLoS Pathog       Date:  2010-06-17       Impact factor: 6.823

7.  Inhibition of the spontaneous apoptosis of neutrophil granulocytes by the intracellular parasite Leishmania major.

Authors:  Eresso Aga; Dörthe M Katschinski; Ger van Zandbergen; Helmut Laufs; Birgit Hansen; Kerstin Müller; Werner Solbach; Tamás Laskay
Journal:  J Immunol       Date:  2002-07-15       Impact factor: 5.422

8.  Evidence that lipopolisaccharide may contribute to the cytokine storm and cellular activation in patients with visceral leishmaniasis.

Authors:  Joanna R Santos-Oliveira; Eduardo G Regis; Cássia R B Leal; Rivaldo V Cunha; Patrícia T Bozza; Alda M Da-Cruz
Journal:  PLoS Negl Trop Dis       Date:  2011-07-12

9.  Toll-like receptors in leishmania infections: guardians or promoters?

Authors:  Marilia S Faria; Flavia C G Reis; Ana Paula C A Lima
Journal:  J Parasitol Res       Date:  2012-03-15

Review 10.  CD28 and CTLA-4 coreceptor expression and signal transduction.

Authors:  Christopher E Rudd; Alison Taylor; Helga Schneider
Journal:  Immunol Rev       Date:  2009-05       Impact factor: 12.988

View more
  10 in total

1.  HLA-DR Class II expression on myeloid and lymphoid cells in relation to HLA-DRB1 as a genetic risk factor for visceral leishmaniasis.

Authors:  Bhawana Singh; Michaela Fakiola; Medhavi Sudarshan; Joyce Oommen; Siddharth Sankar Singh; Shyam Sundar; Jenefer M Blackwell
Journal:  Immunology       Date:  2018-11-22       Impact factor: 7.397

2.  Peripheral Blood Monocytes With an Antiinflammatory Phenotype Display Limited Phagocytosis and Oxidative Burst in Patients With Visceral Leishmaniasis.

Authors:  Neetu Singh; Rajiv Kumar; Shashi Bhushan Chauhan; Christian Engwerda; Shyam Sundar
Journal:  J Infect Dis       Date:  2018-08-24       Impact factor: 5.226

3.  Revisiting the Principles of Designing a Vaccine.

Authors:  Shubhranshu Zutshi; Sunil Kumar; Prashant Chauhan; Bhaskar Saha
Journal:  Methods Mol Biol       Date:  2022

4.  Decreased Frequency and Secretion of CD26 Promotes Disease Progression in Indian Post Kala-azar Dermal Leishmaniasis.

Authors:  Shibabrata Mukherjee; Debanjan Mukhopadhyay; Susmita Ghosh; Joyashree N Barbhuiya; Nilay K Das; Mitali Chatterjee
Journal:  J Clin Immunol       Date:  2015-12-07       Impact factor: 8.317

5.  Leishmania infantum and Leishmania braziliensis: Differences and Similarities to Evade the Innate Immune System.

Authors:  Sarah de Athayde Couto Falcão; Tatiana M G Jaramillo; Luciana G Ferreira; Daniela M Bernardes; Jaime M Santana; Cecília B F Favali
Journal:  Front Immunol       Date:  2016-08-03       Impact factor: 7.561

6.  Impaired activation of lesional CD8+ T-cells is associated with enhanced expression of Programmed Death-1 in Indian Post Kala-azar Dermal Leishmaniasis.

Authors:  Shibabrata Mukherjee; Ritika Sengupta; Debanjan Mukhopadhyay; Claudia Braun; Sneha Mitra; Susmita Roy; Nilay Kanti Das; Uttara Chatterjee; Esther von Stebut; Mitali Chatterjee
Journal:  Sci Rep       Date:  2019-01-24       Impact factor: 4.379

7.  Macrophages as host, effector and immunoregulatory cells in leishmaniasis: Impact of tissue micro-environment and metabolism.

Authors:  Christian Bogdan
Journal:  Cytokine X       Date:  2020-10-12

Review 8.  Determinants of Innate Immunity in Visceral Leishmaniasis and Their Implication in Vaccine Development.

Authors:  Greta Volpedo; Thalia Pacheco-Fernandez; Parna Bhattacharya; Timur Oljuskin; Ranadhir Dey; Sreenivas Gannavaram; Abhay R Satoskar; Hira L Nakhasi
Journal:  Front Immunol       Date:  2021-10-12       Impact factor: 7.561

9.  The Role of Nitric Oxide and Reactive Oxygen Species in the Killing of Leishmania braziliensis by Monocytes from Patients with Cutaneous Leishmaniasis.

Authors:  Pedro Paulo Carneiro; Jacilara Conceição; Michael Macedo; Viviane Magalhães; Edgar M Carvalho; Olivia Bacellar
Journal:  PLoS One       Date:  2016-02-03       Impact factor: 3.240

10.  M2 Polarization of Monocytes-Macrophages Is a Hallmark of Indian Post Kala-Azar Dermal Leishmaniasis.

Authors:  Debanjan Mukhopadhyay; Shibabrata Mukherjee; Susmita Roy; Jane E Dalton; Sunanda Kundu; Avijit Sarkar; Nilay K Das; Paul M Kaye; Mitali Chatterjee
Journal:  PLoS Negl Trop Dis       Date:  2015-10-23
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.